ArticleFolia microbiologica2025
Bacillus toyonensis BAR1, a yellow-pigment producing endophyte of Berberis aristata DC: a potential source of bioactive and antimicrobial compounds.
Article in Folia microbiologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A comprehensive review on bacterial endophytic secondary metabolites: a road map from crude extract to lead molecule production.Frontiers in pharmacology · 2026Review
- Spatiotemporal dynamics of culturable endophytic microorganisms inFrontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herein, we report the isolation and characterization of an endophytic bacterium associated with the Berberis aristata roots to uncover bioactive compounds, particularly antimicrobials, using submerged culture. The bacterial isolate was identified via 16S rDNA sequence analysis and characterized using morphological, microscopic, and biochemical techniques. It was identified as Bacillus toyonensis strain BAR1, a motile, gram-positive, halotolerant bacterium capable of producing yellow pigments. The isolate was cultured under submerged fermentation conditions for secondary metabolites production, followed by their extraction, identification, and in-vitro biological activities evaluation. Colorimetric phytochemical analysis of crude secondary metabolite extract revealed diverse phytochemical classes, including phenolics, alkaloids, tannins, and terpenoids. UV-visible spectrophotometry of the extract identified two yellow pigments, carotenoids and berberine, while GC-MS-based metabolomic profiling detected several important bioactive compounds and peptides, including calein C, carnegine, and deoxyspergualin. The extract demonstrated significant concentration and time dependent antioxidant and antibacterial activities, particularly against multidrug-resistant Enterobacter cloacae, Bacillus subtilis, and Pseudomonas aeruginosa. In conclusion, Bacillus toyonensis BAR1 is a potential microbial factory for sustainable production of bioactive compounds and yellow pigments, with promising applications in pharmaceuticals, textile and food industries, pending further validation.
Indexed as
Identifiers
40911245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.